Works matching Merck %26 Co. Inc.

Results: 5000

APOTEX USA, INC. V. MERCK & CO., INC.

Published in:: Berkeley Technology Law Journal, 2002, v. 17, n. 1, p. 144
Publication type:: Article

Patient Resources from Merck & Co., Inc.

Published in:

Journal of Oncology Navigation & Survivorship, 2014, v. 5, n. 1, p. 6

By:

Shockney, Lillie D.

Publication type:

Article

MERCK & CO. v. TEVA PHARMACEUTICALS USA, INC.

Published in:: Berkeley Technology Law Journal, 2006, v. 21, n. 1, p. 184
Publication type:: Article

The Merck Index von Merck & Co., Inc., New Jersay, 6th Edition, 1162 Seiten. Preis 8 Dollar.

Published in:

Archiv der Pharmazie, 1952, v. 285, n. 6, p. 304, doi. 10.1002/ardp.19522850609

By:

v. Bruchhausen

Publication type:

Article

Product update. Merck & Co., Inc., withdraws Vioxx from the market.

Published in:

2004

By:

Fieler VK

Publication type:

Journal Article

Merck & Co., Inc., Withdraws Vioxx From the Market.

Published in:: Oncology Nursing Forum, 2004, v. 31, n. 6, p. 1188
Publication type:: Article

Physical and Chemical Rationalization for Asymmetric Amplification in Autocatalytic Reactions ( The work reported herein was carried out at the University of Hull, Hull HU6 7RX U.K. Funding from the EPSRC and Merck Co., Inc. is gratefully acknowledged. We also thank J. M. Brown and I. D. Gridnev for stimulating discussions. )

Published in:

Angewandte Chemie, 2004, v. 116, n. 16, p. 2151, doi. 10.1002/ange.200353086

By:

Frederic G. Buono;
Hiroshi Iwamura;
Donna G. Blackmond

Publication type:

Article

Physical and Chemical Rationalization for Asymmetric Amplification in Autocatalytic Reactions ( The work reported herein was carried out at the University of Hull, Hull HU6 7RX U.K. Funding from the EPSRC and Merck Co., Inc. is gratefully acknowledged. We also thank J. M. Brown and I. D. Gridnev for stimulating discussions. )

Published in:

Angewandte Chemie International Edition, 2004, v. 43, n. 16, p. 2099, doi. 10.1002/anie.200353086

By:

Frederic G. Buono;
Hiroshi Iwamura;
Donna G. Blackmond

Publication type:

Article

Flexibility implementation to a global workforce: a case study of Merck and Company, Inc.

Published in:

Community, Work & Family, 2011, v. 14, n. 2, p. 249, doi. 10.1080/13668803.2011.571404

By:

Muse, LoriA.

Publication type:

Article

Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.

Published in:

Tropical Medicine & International Health, 2008, v. 13, n. 5, p. 689, doi. 10.1111/j.1365-3156.2008.02049.x

By:

Thylefors, B.;
Alleman, M. M.;
Twum-Danso, N. A. Y.

Publication type:

Article

The ADVANTAGE Seeding Trial: A Review of Internal Documents.

Published in:

Annals of Internal Medicine, 2008, v. 149, n. 4, p. 251, doi. 10.7326/0003-4819-149-4-200808190-00006

By:

Hill, Kevin P.;
Ross, Joseph S.;
Egilman, David S.;
Krumholz, Harlan M.

Publication type:

Article

The German Connection: Merck and the Flow of Knowledge from Germany to the United States, 1880- 1930.

Published in:

Business & Economic History On-Line, 2011, v. 9, p. 1

By:

Sturchio, Jeffrey L.;
Galambos, Louis

Publication type:

Article

Medical manual is revised, updated, expanded.

Published in:: Urology Times, 2006, v. 34, n. 6, p. 52
Publication type:: Article

Quebec allows Vioxx class-action suit.

Published in:

CMAJ: Canadian Medical Association Journal Supplement, 2007, v. 176, n. 1, p. 20, doi. 10.1503/cmaj.061600

By:

Sibbald, Barbara

Publication type:

Article

Therapeutics: New drugs hit the target.

Published in:

Nature, 2011, v. 474, n. 7350, p. S5, doi. 10.1038/474S5a

By:

Schlütter, Jana

Publication type:

Article

Seven days: 25?31 March 2011.

Published in:: Nature, 2011, v. 471, n. 7340, p. 552, doi. 10.1038/471552a
Publication type:: Article

Prevention of varicella. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Published in:

2007

By:

Marin M;
Güris D;
Chaves SS;
Schmid S;
Seward JF

Publication type:

Journal Article

Prevention of Varicella.

Published in:

MMWR: Morbidity & Mortality Weekly Report, 2007, v. 56, n. RR-4, p. 1

By:

Marin, Mona;
Güris, Dalya;
Chaves, Sandra S.;
Schmid, Scott;
Seward, Jane F.

Publication type:

Article

Update on Supply of Vaccines Containing Varicella-Zoster Virus.

Published in:: MMWR: Morbidity & Mortality Weekly Report, 2007, v. 56, n. 18, p. 453
Publication type:: Article

Licensure of Varicella Virus Vaccine, Live.

Published in:: MMWR: Morbidity & Mortality Weekly Report, 1995, v. 44, n. 13, p. 264
Publication type:: Article

Characterization and Management of Adverse Reactions in Patients with Endometrial Carcinoma Receiving Lenvatinib plus Pembrolizumab (Study 111/KEYNOTE-146): Nurse Roles in Patient Education and Adverse-Reaction Management.

Published in:

Journal of Oncology Navigation & Survivorship, 2020, v. 11, n. 11, p. 439

By:

Soldan, Krysten;
Johns, Carolyn;
Taylor, Matthew H.;
Gillis, Kathryn;
Orlowski, Robert;
Min Ren;
Makker, Vicky

Publication type:

Article

Merck collaborates with African and Asian Universities to build diabetes and hypertension healthcare capacity in the two continents.

Published in:: African Journal of Diabetes Medicine, 2015, v. 13, n. 1, p. 4
Publication type:: Article

Watch for urolithiasis in HIV patients taking indinavir.

Published in:

Urology Times, 1998, v. 26, n. 8, p. 4

By:

Bauman, Norman

Publication type:

Article

Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.

Published in:

Health Policy & Planning, 2015, v. 30, n. 7, p. 1580, doi. 10.1093/humrep/dev102

By:

Kaislasuo, Janina;
Heikinheimo, Oskari;
Lähteenmäki, Pekka;
Suhonen, Satu

Publication type:

Article

HIV vaccine trial halted.

Published in:

2007

By:

Ahmad, Sharon

Publication type:

Product Review

The First American Cough Conference.

Published in:

2008

By:

Dicpinigaitis, Peter V.

Publication type:

Proceeding

Author Correction: Reinforcing the supply chain of umifenovir and other antiviral drugs with retrosynthetic software.

Published in:

2022

By:

Lin, Yingfu;
Zhang, Zirong;
Mahjour, Babak;
Wang, Di;
Zhang, Rui;
Shim, Eunjae;
McGrath, Andrew;
Shen, Yuning;
Brugger, Nadia;
Turnbull, Rachel;
Trice, Sarah;
Jasty, Shashi;
Cernak, Tim

Publication type:

Correction Notice

LC today: industry & applications news October 2016.

Published in:

Liquid Crystals Today, 2016, v. 25, n. 4, p. 91, doi. 10.1080/1358314X.2016.1245695

By:

Wei, David

Publication type:

Article

Liquid Crystal News V.

Published in:

Liquid Crystals Today, 2011, v. 20, n. 3, p. 98, doi. 10.1080/1358314X.2011.591991

By:

Siemianowski, Simon

Publication type:

Article

Enabling a New Way of Working through Inclusion and Social Media: A Case Study.

Published in:

2013

By:

Guenard, Robert;
Katz, Judith;
Bruno, Samantha;
Lipa, Marty

Publication type:

Case Study

Vaccine Seems to Have Affected U.S. Rotavirus Pattern: C.D.C.

Published in:: Clinical Infectious Diseases, 2008, v. 47, n. 5, p. iv
Publication type:: Article

FDA Approves New HIV Integrase Inhibitor, Merck Says.

Published in:: Clinical Infectious Diseases, 2007, v. 45, n. 12, p. iv
Publication type:: Article

Quadrivalent Human Papillomavirus (HPV) Vaccine.

Published in:

Clinical Infectious Diseases, 2007, v. 45, n. 6, p. v

By:

Deresinski, Stan

Publication type:

Article

Efficacy of Raltegravir Sustained in HIV Patients.

Published in:

Clinical Infectious Diseases, 2007, v. 45, n. 6, p. iv, doi. 10.1086/521992

By:

Kaye, Donald

Publication type:

Article

Merck Wins U.S. Priority Review for HIV Drug.

Published in:: Clinical Infectious Diseases, 2007, v. 45, n. 5, p. iv
Publication type:: Article

Merck Ending Lobbying for Mandatory Gardasil Vaccine.

Published in:

Clinical Infectious Diseases, 2007, v. 44, n. 8, p. iv, doi. 10.1086/516813

By:

Kaye, Donald

Publication type:

Article

GILEAD, MERCK, BRISTOL-MYERS TO COMBINE HIV DRUGS.

Published in:: Clinical Infectious Diseases, 2004, v. 39, n. 1, p. iv
Publication type:: Article

14 day Singulair packs.

Published in:: 2009
Publication type:: Product Review

TGA approves Janumet.

Published in:: 2009
Publication type:: Product Review

Merck/Schering Plough deal.

Published in:: Australian Journal of Pharmacy, 2009, v. 90, n. 1067, p. 57
Publication type:: Article

Medco becomes standalone firm.

Published in:

American Journal of Health-System Pharmacy, 2003, v. 60, n. 19, p. 1940, doi. 10.1093/ajhp/60.19.1940

By:

Thompson, Cheryl A.

Publication type:

Article

A five-year evaluation of reports of overdose with indinavir sulfate.

Published in:

Pharmacoepidemiology & Drug Safety, 2003, v. 12, n. 6, p. 449, doi. 10.1002/pds.868

By:

Heidi P. Lehman;
Joan O. Benson;
Paul R. Beninger;
Charles A. Anderson;
Steven J. Blumenthal;
Robert G. Sharrar

Publication type:

Article

Correction to: Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061.

Published in:

2021

By:

Van Cutsem, Eric;
Amonkar, Mayur;
Fuchs, Charles S.;
Alsina, Maria;
Özgüroğlu, Mustafa;
Bang, Yung-Jue;
Chung, Hyun Cheol;
Muro, Kei;
Goekkurt, Eray;
Benson III, Al B.;
Sun, Weijing;
Wainberg, Zev A.;
Norquist, Josephine M.;
Chen, Xinqun;
Shih, Chie-Schin;
Shitara, Kohei

Publication type:

Correction Notice

The GAVI Alliance.

Published in:: Journal of Global Health, 2013, v. 3, n. 1, p. 11, doi. 10.7189/jogh.03.010202
Publication type:: Article

Population PK Analyses of Ubrogepant (MK‐1602), a CGRP Receptor Antagonist: Enriching In‐Clinic Plasma PK Sampling With Outpatient Dried Blood Spot Sampling.

Published in:

Journal of Clinical Pharmacology, 2018, v. 58, n. 3, p. 294, doi. 10.1002/jcph.1021

By:

Li, Chi‐Chung;
Dockendorf, Marissa;
Kowalski, Ken;
Yang, Bei;
Xu, Yang;
Xie, Iris;
Kleijn, Huub Jan;
Bosch, Rolien;
Jones, Christopher;
Thornton, Bob;
Marcantonio, Eugene E.;
Voss, Tiffini;
Bateman, Kevin P.;
Kothare, Prajakti A.

Publication type:

Article

NEWS.

Published in:: Nursing Ethics, 2007, v. 14, n. 4, p. 558, doi. 10.1177/0969733007077892
Publication type:: Article

FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP).

Published in:: MMWR: Morbidity & Mortality Weekly Report, 2010, v. 59, n. 20, p. 630
Publication type:: Article

Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine.

Published in:

MMWR: Morbidity & Mortality Weekly Report, 2010, v. 59, n. 17, p. 1

By:

Marin, Mona;
Broder, Karen R.;
Temte, Jonathan L.;
Snider, Dixie E.;
Seward, Jane F.

Publication type:

Article

Continued Shortage of Haemophilus inluenzae Type b (Hib) Conjugate Vaccines and Potential Implications for Hib Surveillance -- United States, 2008.

Published in:

MMWR: Morbidity & Mortality Weekly Report, 2008, v. 57, n. 46, p. 1252

By:

Coronado, F.;
Brown, K.;
Cohn, A.;
Messonnier, N.;
Clark, T. A.;
Jackson, M.

Publication type:

Article

AMERICAN MANAGER OF THE YEAR.

Published in:: Management Review, 1990, v. 79, n. 11, p. 6
Publication type:: Article